• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.

作者信息

Ram Prasanna, Mandal Swarnendu, K Das Manoj, Nayak Prasant

机构信息

Department of Urology, All India Institute of Medical Sciences, Bhubaneshwar, India.

出版信息

Prostate. 2023 May;83(6):613. doi: 10.1002/pros.24489. Epub 2023 Jan 30.

DOI:10.1002/pros.24489
PMID:36717109
Abstract
摘要

相似文献

1
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.基因畸变对镭-223治疗骨转移去势抵抗性前列腺癌疗效的影响。
Prostate. 2023 May;83(6):613. doi: 10.1002/pros.24489. Epub 2023 Jan 30.
2
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.镭-223 二氯化物对去势抵抗性前列腺癌伴骨转移患者症状性骨骼事件的影响：来自一项 3 期、双盲、随机试验的结果。
Lancet Oncol. 2014 Jun;15(7):738-46. doi: 10.1016/S1470-2045(14)70183-4. Epub 2014 May 13.
3
[Targeted radionuclide therapy for castration-resistant prostate cancer].[去势抵抗性前列腺癌的靶向放射性核素治疗]
Nihon Rinsho. 2014 Dec;72(12):2181-5.
4
Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer.反驳观点：在有症状的转移性去势抵抗性前列腺癌中，多西他赛和镭-223应首先使用哪一种？镭-223是骨转移为主的有症状转移性去势抵抗性前列腺癌的首选治疗方法。
Clin Adv Hematol Oncol. 2015 May;13(5):293-8.
5
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.镭-223 在转移性去势抵抗性前列腺癌中的最佳应用。
J Formos Med Assoc. 2017 Nov;116(11):825-836. doi: 10.1016/j.jfma.2017.04.005. Epub 2017 Oct 16.
6
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.遗传异常对镭-223 治疗去势抵抗性前列腺癌伴骨转移反应的影响。
Prostate. 2022 Sep;82(12):1202-1209. doi: 10.1002/pros.24375. Epub 2022 Jun 2.
7
Comment on: 'Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer' by De Vincentis et al.对De Vincentis等人所著《DNA损伤修复缺陷对转移性去势抵抗性前列腺癌中镭-223反应及总生存的影响》的评论
Eur J Cancer. 2021 Feb;144:392-394. doi: 10.1016/j.ejca.2020.09.041. Epub 2020 Dec 3.
8
Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Clinical Development and Use in Contemporary Practice.镭-223用于转移性去势抵抗性前列腺癌：临床开发及在当代实践中的应用
J Med Imaging Radiat Sci. 2019 Dec;50(4S1):S26-S30. doi: 10.1016/j.jmir.2019.05.006. Epub 2019 Jun 21.
9
[Radium-223 treatment of bone metastases from castration-resistant prostate cancer].[镭-223治疗去势抵抗性前列腺癌骨转移]
Ugeskr Laeger. 2014 Jul 21;176(30):1399-402.
10
Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
J Urol. 2015 Mar;193(3):847-8. doi: 10.1016/j.juro.2014.12.077. Epub 2014 Dec 18.